Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.03 USD | +1.57% | +7.69% | +39.57% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
Financials (USD)
Sales 2024 * | 2.19M | Sales 2025 * | 2.67M | Capitalization | 6.5B |
---|---|---|---|---|---|
Net income 2024 * | -512M | Net income 2025 * | -588M | EV / Sales 2024 * | 2,346 x |
Net cash position 2024 * | 1.37B | Net cash position 2025 * | 846M | EV / Sales 2025 * | 2,120 x |
P/E ratio 2024 * |
-12.6
x | P/E ratio 2025 * |
-11.1
x | Employees | 411 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.08% |
Latest transcript on Revolution Medicines, Inc.
1 day | +1.57% | ||
1 week | +7.69% | ||
Current month | +7.38% | ||
1 month | +14.63% | ||
3 months | +37.23% | ||
6 months | +84.22% | ||
Current year | +39.57% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Jack Anders
DFI | Director of Finance/CFO | 47 | 18-07-31 |
Wally Reiher
CTO | Chief Tech/Sci/R&D Officer | - | 15-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Alexis Borisy
BRD | Director/Board Member | 52 | 14-10-31 |
Sandra Horning
BRD | Director/Board Member | 75 | Nov. 08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - | |
0.05% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 40.03 | +1.57% | 972,552 |
24-05-17 | 39.41 | +1.08% | 1,118,299 |
24-05-16 | 38.99 | -1.02% | 1,005,083 |
24-05-15 | 39.39 | +5.38% | 1,343,383 |
24-05-14 | 37.38 | +0.56% | 947,182 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.57% | 6.5B | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- RVMD Stock